PCOS to PMOS: Are We Renaming the Syndrome Instead of Rethinking It?

PCOS to PMOS: Are We Renaming the Syndrome Instead of Rethinking It?Few conditions in medicine have undergone as many identity changes as what we currently call Polycystic Ovary Syndrome (PCOS).Since Stein and Leventhal first described the condition in 1935, it has appeared under several names—Sclerocystic Ovaries, Polycystic Ovaries, Hyperthecosis Ovarii, Polycystic Ovary Syndrome, and now, following an international consensus proposal, Polyendocrine Metabolic Ovarian Syndrome (PMOS).The motivation behind the latest change is understandable. The term “PCOS” is misleading. Many women with the syndrome have neither polycystic ovaries nor ovarian cysts. The disorder affects multiple physiological systems and extends far beyond the reproductive tract.Yet a fundamental question remains.Will a new name change the lives of women living with this condition?For decades, the ovary became the focus of attention. We surgically removed wedges of ovarian tissue. We later introduced ovarian drilling. We blamed the ovary because it was the most visible manifestation of the syndrome.But what if the ovary was never the primary problem?What if it was responding to biological events occurring elsewhere?In an earlier opinion article, we proposed that the polycystic ovary is largely an epiphenomenon—a consequence rather than the origin of the disease process. In a subsequent study, we further hypothesised that excess weight gain above an individual’s physiological baseline may be the principal precipitating factor in the majority of women who develop PCOS. While this hypothesis requires further prospective confirmation, it provides a framework that deserves serious consideration.This perspective also helps explain an important clinical observation.Many women who achieve sustained weight loss experience restoration of ovulation, regular menstrual cycles, improved fertility and marked improvement in metabolic abnormalities. Established hirsutism, however, often persists because terminal hair follicles that have already undergone androgen-dependent transformation seldom return completely to their previous state and frequently require cosmetic hair removal.These observations suggest that many features of the syndrome are reversible consequences of an upstream process, while others become permanent footprints of earlier disease.If this model is correct, then both “PCOS” and “PMOS” describe manifestations rather than the initiating event.The current discussion therefore extends beyond terminology.It asks how medicine should name disease.Should we name diseases after what we observe?Or should we strive to name them according to their underlying pathophysiology?History reminds us that descriptive names often become obsolete as science advances. The greatest breakthroughs in medicine have rarely resulted from changing terminology. They have resulted from discovering causes.Perhaps the most important question is not whether PCOS should become PMOS.Perhaps it is whether we have yet identified the biological event that truly deserves to be in the name.Until then, we may simply be replacing one descriptive label with another.Patients deserve more than better terminology.They deserve earlier recognition, more effective prevention, treatments directed at root causes, and a deeper understanding of the biology that drives the syndrome.Medicine advances not by finding better names for diseases, but by finding their true causes.If this article stimulates discussion, encourages new research, or prompts us to look beyond labels and towards mechanisms, it will have served its purpose.